LH

Laboratory Corp
NYSE

Real-time Quotes | Nasdaq Last Sale

259.83
+1.28
+0.50%
Closed 16:12 06/14 EDT
OPEN
257.93
PREV CLOSE
258.55
HIGH
260.22
LOW
257.24
VOLUME
620.47K
TURNOVER
--
52 WEEK HIGH
280.69
52 WEEK LOW
155.65
MARKET CAP
25.39B
P/E (TTM)
9.66
1D
5D
1M
3M
1Y
5Y
Laboratory Corp. of America Holdings stock outperforms market on strong trading day
marketwatch.com · 13h ago
Labcorp and OmniSeq launch INSIGHT NGS platform
Labcorp ([[LH]] -0.1%) and OmniSeq announce the launch of a comprehensive genomic and immune profiling, tissue-based test that integrates next-generation sequencing ((NGS)) technology called OmniSeq INSIGHT.The test is designed to advance
Seekingalpha · 18h ago
Labcorp And OmniSeq Launch INSIGHT Sequencing Platform To 'Advance Precision Oncology'
 Labcorp (NYSE:LH), a leading global life sciences company, and OmniSeq, a CAP-accredited, molecular diagnostic innovation of Roswell Park Comprehensive Cancer Center, today announced the launch of OmniSeq INSIGHT℠,
Benzinga · 18h ago
Labcorp And OmniSeq Launch INSIGHT℠, Next-Generation Sequencing Platform to Advance Precision Oncology
/PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, and OmniSeq, a CAP-accredited, molecular diagnostic innovation of Roswell Park Comprehensive Cancer Center, today announced the launch of OmniSeq INSIGHT℠, a comprehensive genomic ...
PR Newswire - PRF · 18h ago
Laboratory Corp of America, OmniSeq Launch Genomic, Immune Profiling Test OmniSeq INSIGHT
MT Newswires · 21h ago
BRIEF-Sera Prognostics Inc Files For IPO Of Up To $75 Mln Of Class A Common Stock
reuters.com · 3d ago
Laboratory Corp Of America Holdings (LH) EVP, Chief Legal Officer Der Vaart Sandra D Van Sold ...
GuruFocus News · 4d ago
Laboratory Corp. of America Holdings stock falls Wednesday, underperforms market
marketwatch.com · 5d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LH. Analyze the recent business situations of Laboratory Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LH stock price target is 303.83 with a high estimate of 339.00 and a low estimate of 273.00.
EPS
Institutional Holdings
Institutions: 1.21K
Institutional Holdings: 98.56M
% Owned: 100.88%
Shares Outstanding: 97.70M
TypeInstitutionsShares
Increased
293
6.95M
New
101
1.07M
Decreased
326
6.02M
Sold Out
85
1.33M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.25%
Healthcare Providers & Services
-0.24%
Key Executives
President/Chief Executive Officer/Director
Adam Schechter
Chief Financial Officer/Executive Vice President
Glenn Eisenberg
Chief Human Resource Officer/Executive Vice President
Judith Seltz
Executive Vice President/Chief Technology Officer/Chief Information Officer
Lance Berberian
Executive Vice President/Chief Marketing Officer
Amy Summy
Executive Vice President/Chief Compliance Officer/Secretary
Sandra Van Der Vaart
Executive Vice President
Brian Caveney
Executive Vice President
Paul Kirchgraber
Executive Vice President
Mark Schroeder
Senior Vice President/Chief Accounting Officer
Peter Wilkinson
Lead Director/Independent Director
Peter Neupert
Independent Director
Kerrii Anderson
Independent Director
Jean-Luc Belingard
Independent Director
Jeffrey Davis
Independent Director
D. Gary Gilliland
Independent Director
R. Sanders Williams
Independent Director
Garheng Kong
Independent Director
Richelle Parham
Independent Director
Kathryn Wengel
Independent Director
Robert Williams
No Data
  • All
  • Financials
  • Insiders
More
About LH
Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Webull offers kinds of Laboratory Corp. of America Holdings stock information, including NYSE:LH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LH stock methods without spending real money on the virtual paper trading platform.